309 related articles for article (PubMed ID: 34960055)
21. Prostate cancer immunotherapy: where are we and where are we going?
De Velasco MA; Uemura H
Curr Opin Urol; 2018 Jan; 28(1):15-24. PubMed ID: 29095729
[TBL] [Abstract][Full Text] [Related]
22. Arginase: a critical regulator of nitric oxide synthesis and vascular function.
Durante W; Johnson FK; Johnson RA
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639
[TBL] [Abstract][Full Text] [Related]
23. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells.
Li H; Meininger CJ; Hawker JR; Haynes TE; Kepka-Lenhart D; Mistry SK; Morris SM; Wu G
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E75-82. PubMed ID: 11120661
[TBL] [Abstract][Full Text] [Related]
24. MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge.
Nelin LD; Wang X; Zhao Q; Chicoine LG; Young TL; Hatch DM; English BK; Liu Y
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C632-40. PubMed ID: 17442735
[TBL] [Abstract][Full Text] [Related]
25. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.
Chang CI; Liao JC; Kuo L
Cancer Res; 2001 Feb; 61(3):1100-6. PubMed ID: 11221839
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.
Raber P; Ochoa AC; Rodríguez PC
Immunol Invest; 2012; 41(6-7):614-34. PubMed ID: 23017138
[TBL] [Abstract][Full Text] [Related]
27. Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS.
Elms S; Chen F; Wang Y; Qian J; Askari B; Yu Y; Pandey D; Iddings J; Caldwell RB; Fulton DJ
Am J Physiol Heart Circ Physiol; 2013 Sep; 305(5):H651-66. PubMed ID: 23792682
[TBL] [Abstract][Full Text] [Related]
28. RNA-seq transcriptional profiling of Leishmania amazonensis reveals an arginase-dependent gene expression regulation.
Aoki JI; Muxel SM; Zampieri RA; Laranjeira-Silva MF; Müller KE; Nerland AH; Floeter-Winter LM
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006026. PubMed ID: 29077741
[TBL] [Abstract][Full Text] [Related]
29. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase.
Cook HT; Jansen A; Lewis S; Largen P; O'Donnell M; Reaveley D; Cattell V
Am J Physiol; 1994 Oct; 267(4 Pt 2):F646-53. PubMed ID: 7524362
[TBL] [Abstract][Full Text] [Related]
30. [New insights into arginase. Part II. Role in physiology and pathology].
Mielczarek-Puta M; Chrzanowska A; Graboń W; Barańczyk-Kuźma A
Postepy Hig Med Dosw (Online); 2008 May; 62():214-21. PubMed ID: 18480737
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
[TBL] [Abstract][Full Text] [Related]
32. Classical and slow-binding inhibitors of human type II arginase.
Colleluori DM; Ash DE
Biochemistry; 2001 Aug; 40(31):9356-62. PubMed ID: 11478904
[TBL] [Abstract][Full Text] [Related]
33. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.
Hesse M; Modolell M; La Flamme AC; Schito M; Fuentes JM; Cheever AW; Pearce EJ; Wynn TA
J Immunol; 2001 Dec; 167(11):6533-44. PubMed ID: 11714822
[TBL] [Abstract][Full Text] [Related]
34. The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer.
Nair SS; Weil R; Dovey Z; Davis A; Tewari AK
Urol Clin North Am; 2020 Nov; 47(4S):e17-e54. PubMed ID: 33446323
[TBL] [Abstract][Full Text] [Related]
35. L-arginine metabolism and its impact on host immunity against Leishmania infection.
Wanasen N; Soong L
Immunol Res; 2008; 41(1):15-25. PubMed ID: 18040886
[TBL] [Abstract][Full Text] [Related]
36. Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.
Tate DJ; Vonderhaar DJ; Caldas YA; Metoyer T; Patterson JR; Aviles DH; Zea AH
J Hematol Oncol; 2008 Sep; 1():14. PubMed ID: 18817562
[TBL] [Abstract][Full Text] [Related]
37. TIPE2 negatively regulates inflammation by switching arginine metabolism from nitric oxide synthase to arginase.
Lou Y; Zhang G; Geng M; Zhang W; Cui J; Liu S
PLoS One; 2014; 9(5):e96508. PubMed ID: 24806446
[TBL] [Abstract][Full Text] [Related]
38. Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer.
Gannon PO; Godin-Ethier J; Hassler M; Delvoye N; Aversa M; Poisson AO; Péant B; Alam Fahmy M; Saad F; Lapointe R; Mes-Masson AM
PLoS One; 2010 Aug; 5(8):e12107. PubMed ID: 20711410
[TBL] [Abstract][Full Text] [Related]
39. Arginase in glomerulonephritis.
Waddington SN
Kidney Int; 2002 Mar; 61(3):876-81. PubMed ID: 11849441
[TBL] [Abstract][Full Text] [Related]
40. Arginase enzymes in the human prostate: A molecular biological and immunohistochemical approach.
Rahardjo HE; Ückert S; Tsikas D; Hedlund P; Bannowsky A; Kuczyk MA; Kedia GT
Andrologia; 2019 Oct; 51(9):e13349. PubMed ID: 31482616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
